Methyldopa Tablets Shortage
Last Updated: November 17, 2023
Status: Resolved
Products Affected - Description
-
- Methyldopa oral tablet, Accord, 250 mg, bottle, 100 count, NDC 16729-0030-01 - discontinued
- Methyldopa oral tablet, Accord, 250 mg, bottle, 500 count, NDC 16729-0030-16 - discontinued
- Methyldopa oral tablet, Accord, 500 mg, bottle, 100 count, NDC 16729-0031-01 - discontinued
- Methyldopa oral tablet, Accord, 500 mg, bottle, 500 count, NDC 16729-0031-16 - discontinued
- Methyldopa oral tablet, Mylan (Viatris), 250 mg, bottle, 100 count, NDC 00378-0611-01 - discontinued
- Methyldopa oral tablet, Mylan (Viatris), 500 mg, bottle, 100 count, NDC 00378-0421-01 - discontinued
Reason for the Shortage
-
- Accord discontinued methyldopa tablets.
- Chartwell launched methyldopa tablets in November 2023.
- Mylan discontinued methyldopa in June 2021.
Available Products
-
- Methyldopa oral tablet, Chartwell, 250 mg, bottle, 90 count, NDC 62135-0321-90
- Methyldopa oral tablet, Chartwell, 250 mg, bottle, 180 count, NDC 62135-0321-18
- Methyldopa oral tablet, Chartwell, 500 mg, bottle, 90 count, NDC 62135-0322-90
- Methyldopa oral tablet, Chartwell, 500 mg, bottle, 180 count, NDC 62135-0322-18
Updated
Updated November 17, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. Created November 10, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.